Table of Content



1. Executive Summary


2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Industry Drivers and Challenges
2.3: Supply Chain


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1: Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2: Trends and Forecast for the MENA GDP
3.3: Trends and Forecast for the MENA Population
3.4: Trends and Forecast for the MENA Inflation rate
3.5: Trends and Forecast for the MENA Unemployment Rate
3.6: Trends and Forecast for the MENA Per Capita Income
3.7: Global Active Pharmaceutical Ingredient Market Trends and Forecast
3.8: Middle Eastern and North African Active Pharmaceutical Ingredient Market Trends and Forecast
3.9: Middle Eastern and North African Active Pharmaceutical Ingredient Market by Synthesis Type
3.9.1: Synthetic Chemical
3.9.2: Biotech and Biologics
3.9.3: Plant Extracts
3.9.4: Fermentation
3.9.5: Others
3.10: Middle Eastern and North African Active Pharmaceutical Ingredient Market by Manufacturer Type
3.10.1: Captive APIs
3.10.2: Merchant APIs
3.11: Middle Eastern and North African Active Pharmaceutical Ingredient Market by Therapeutic Areas
3.11.1: Cardiology
3.11.2: Oncology
3.11.3: Neurology
3.11.4: Orthopedics
3.11.5: Ophthalmology
3.11.6: Pulmonology
3.11.7: Aliment
3.11.8: Anti-Inflammatory
3.11.9: Others
3.12: Middle Eastern and North African Active Pharmaceutical Ingredient Market by Product Form
3.12.1: Liquid APIs
3.12.2: Powder APIs
3.13: Middle Eastern and North African Active Pharmaceutical Ingredient Market by Molecule
3.13.1: Large Molecules
3.13.2: Small Molecules
3.14: Middle Eastern and North African African Active Pharmaceutical Ingredient Market by Drug type
3.14.1: Branded
3.14.2: Generic
3.14.3: Over-the-Counter (OTC)


4. Competitor Analysis
4.1: Product Portfolio Analysis
4.2: Market Share Analysis
4.3: Operational Integration
4.4: Geogrsphical Reach
4.5: Porter’s Five Forces Analysis


5. Growth Opportunities and Strategic Analysis
5.1: Growth Opportunity Analysis
5.1.1: Growth Opportunities for the Middle Eastern and North African Active Pharmaceutical Ingredient Market by Synthesis Type
5.1.2: Growth Opportunities for the Middle Eastern and North African Active Pharmaceutical Ingredient Market by Manufacturer Type
5.1.3: Growth Opportunities for the Middle Eastern and North African Active Pharmaceutical Ingredient Market by Therapeutic Area
5.1.4: Growth Opportunities for the Middle Eastern and North African Active Pharmaceutical Ingredient Market by Product Form
5.1.5: Growth Opportunities for the Middle Eastern and North African Active Pharmaceutical Ingredient Market by Molecule
5.1.6: Growth Opportunities for the Middle Eastern and North African Active Pharmaceutical Ingredient Market by Drug Type
5.2: Emerging Trends in the Middle Eastern and North African Active Pharmaceutical Ingredient Market
5.3: Strategic Analysis
5.3.1: New Technological Development
5.3.2: Merger, Acquisition, and Joint Venture in the Middle Eastern and North African Active Pharmaceutical Ingredient Market
5.3.3: Capacity Expansion of the Middle Eastern and North African Active Pharmaceutical Ingredient Market
5.3.4: Certification and Licensing


6. Company Profiles of Leading Players
6.1: Pfizer, Inc.
6.2: Teva Pharmaceutical Industries Ltd.
6.3: GlaxoSmithKline (GSK)
6.4: Sun Pharmaceutical Industries Ltd.
6.5: Novartis International AG
6.6: Aurobindo Pharma Ltd.
6.7: Merck & Co.
6.8: BASF SE.
6.9: Julphar Pharmaceutical Company.
6.10: AbbVie, Inc.